(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone

We are (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone CAS:915095-87-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone
CAS.NO:  915095-87-3
Synonyms:
(S)-(2-Chloro-5-iodophenyl)(4-(tetrahydrofuran-3-yloxy)phenyl)methanone
Empagliflozin intermediate
(2-CHLORO-5-IODOPHENYL)[4-[[(3S)-TETRAHYDRO-3-FURANYL)OXY]PHENYL]METHANONE
Methanone, (2-chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]-

Molecular Formula: C17H14ClIO3
Molecular Weight:  428.64900

Physical and Chemical Properties:
Density: 1.639±0.1 g/cm3
BBoiling point: 525.9±50.0 °C (760 mmHg)
Melting point: /
Flash point: 272℃
Refractive index: /

Specification:
Appearance:White Powder
Purity:≥99.0%
Total Impurity:≤0.5%
Water:≤0.5%
Heavy metals:≤10ppm
Volatile:≤0.1%
Inorganic salt:≤0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Keep in cool & dry place.Keep away from strong light and heat.
Application:Intermediates of Empagliflozin CAS:864070-44-0.

Related News: Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.Propyl bromoacetate CAS:35223-80-4 Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.picolinic acid CAS:98-98-6 Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.Ácido [4- (N-fenilanilino) fenil] borónico CAS:201802-67-7 You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.